Business
Promising antibody response in Australians given Novavax COVID-19 vaccine – Sydney Morning Herald
An early-stage trial of a promising COVID-19 vaccine found high levels of coronavirus-neutralising antibodies in Australians who volunteered to get the experimental injection.
Participants who received two doses of the vaccine three weeks apart had neutralising antibody levels roughly four times higher than a group of 32 patients who had recovered from COVID-19.
“We are extremely excited,” Novavax research chief Gregory Glenn said.
“At this point, it looks extremely promising … We have a technology that is extremely good at inducing functional immunity….
-
Noosa News23 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours agoHelp to make recycling stick
-
Noosa News15 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Noosa News23 hours agoFive quick hits: Tom Dearden’s magic goes down in Maroons folklore after downing Blues in Origin decider